Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials

Wang, S. V., Schneeweiss, S., Initiative, R.-D., Franklin, J. M., Desai, R. J., Feldman, W., Garry, E. M., Glynn, R. J., Lin, K. J., Paik, J., et al. (2023) · JAMA · doi:10.1001/jama.2023.4221 · Cited by 428

Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients

Wang, X., Guo, X., Xin, Q., Pan, Y., Hu, Y., Li, J., Chu, Y., Feng, Y., & Wang, Q. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa721 · Cited by 363

Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy

Zhang, Q., Xiang, R., Huo, S., Zhou, Y., Jiang, S., Wang, Q., & Yu, F. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00653-w · Cited by 364

Covid-19 vaccines production and societal immunization under the serendipity-mindsponge-3D knowledge management theory and conceptual framework

Vuong, Q., Le, T.-T., La, V., Huyền, N. T. T., Ho, M., Khuc, Q. V., & Nguyen, M. (2022) · Humanities and Social Sciences Communications · doi:10.1057/s41599-022-01034-6 · Cited by 334

Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019

Rajter, J. C., Sherman, M. S., Fatteh, N., Vogel, F., Sacks, J., & Rajter, J.-J. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.10.009 · Cited by 317

Potential impact of seasonal forcing on a SARS-CoV-2 pandemic

Neher, R. A., Dyrdak, R., Druelle, V., Hodcroft, E. B., & Albert, J. (2020) · Swiss Medical Weekly · doi:10.4414/smw.2020.20224 · Cited by 284

Misinformation about COVID-19: evidence for differential latent profiles and a strong association with trust in science

Agley, J. D., & Xiao, Y. (2021) · BMC Public Health · doi:10.1186/s12889-020-10103-x · Cited by 266

Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis

Kim, M. S., An, M. H., Kim, W. J., & Hwang, T.-H. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003501 · Cited by 251

COVID-SCORE: a global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10)

Lazarus, J. V., Ratzan, S., Palayew, A., Billari, F. C., Binagwaho, A., Kimball, S., Larson, H. J., Melegaro, A., Rabin, K., White, T. M., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0240011 · Cited by 232

Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative

Bennett, T. D., Moffitt, R. A., Hajagos, J., Amor, B., Anand, A., Bissell, M. M., Bradwell, K. R., Bremer, C., Byrd, J. B., Denham, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.16901 · Cited by 230

How COVID-19 has fundamentally changed clinical research in global health

Park, J., Mogg, R., Smith, G. E., Nakimuli‐Mpungu, E., Jehan, F., Rayner, C. R., Condo, J. U., Decloedt, E. H., Nachega, J. B., Reis, G., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30542-8 · Cited by 229

Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19

Singh, B., Ryan, H., Kredo, T., Chaplin, M., & Fletcher, T. E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013587.pub2 · Cited by 225

A double-edged sword—telemedicine for maternal care during COVID-19: findings from a global mixed-methods study of healthcare providers

Galle, A., Semaan, A. T., Huysmans, E., Audet, C., Asefa, A., Delvaux, T., Afolabi, B. B., Ayadi, A. M. E., & Beňová, L. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-004575 · Cited by 207

False individual patient data and zombie randomised controlled trials submitted to Anaesthesia

Carlisle, J. B. (2021) · Anaesthesia · doi:10.1111/anae.15263 · Cited by 173

The carnage of substandard research during the COVID-19 pandemic: a call for quality

Bramstedt, K. A. (2020) · Journal of Medical Ethics · doi:10.1136/medethics-2020-106494 · Cited by 170

COVID-19: a review

Papadopoulos, C., Chong, S. J. K., & Jaunoo, S. (2020) · IJS Short Reports · doi:10.1097/sr9.0000000000000007 · Cited by 165

SARS-CoV-2: characteristics and current advances in research

Yang, Y., Xiao, Z., Ye, K., He, X., Sun, B., Qin, Z., Yu, J., Yao, J., Wu, Q., Bao, Z., et al. (2020) · Virology Journal · doi:10.1186/s12985-020-01369-z · Cited by 168

Malaria and COVID-19: unmasking their ties

Hussein, M. I. H., Albashir, A. A. D., Elawad, O. A. M. A., & Homeida, A. (2020) · Malaria Journal · doi:10.1186/s12936-020-03541-w · Cited by 156

High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors

Zhao, Y., Du, X., Duan, Y., Pan, X., Sun, Y., You, T., Han, L., Jin, Z., Shang, W., Yu, J., et al. (2021) · Protein & Cell · doi:10.1007/s13238-021-00836-9 · Cited by 155

Natural history of COVID-19 and therapeutic options

Gautret, P., Million, M., Jarrot, P., Camoin‐Jau, L., Colson, P., Fenollar, F., Léone, M., Scola, B. L., Devaux, C. A., Gaubert, J. Y., et al. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1847640 · Cited by 158

COVID-19 and the Kidneys: An Update

Benedetti, C., Waldman, M. A., Zaza, G., Riella, L. V., & Cravedi, P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00423 · Cited by 145

Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

Rivera, D. R. R., Peters, S., Panagiotou, O. A., Shah, D. P., Kuderer, N. M., Hsu, C., Rubinstein, S. M., Lee, B. J., Choueiri, T. K., Lopes, G. D. L., Jr., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0941 · Cited by 135

Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis

Elavarasi, A., Prasad, M., Seth, T., Sahoo, R. K., Madan, K., Nischal, N., Soneja, M., Sharma, A., Maulik, S. K., Shalimar, S., et al. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06146-w · Cited by 125

Health informatics and EHR to support clinical research in the COVID-19 pandemic: an overview

Dagliati, A., Malovini, A. L., Tibollo, V., & Bellazzi, R. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa418 · Cited by 127

Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future

Godman, B., Haque, M., Islam, S., Iqbal, S., Urmi, U. L., Kamal, Z. M., Shuvo, S. N., Rahman, A., Kamal, M., Haque, M., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.585832 · Cited by 114

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019

Bansal, P., Goyal, A., Cusick, A. S., Lahan, S., Dhaliwal, H. S., Bhyan, P., Bhattad, P. B., Aslam, F., Ranka, S., Dalia, T., et al. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1839959 · Cited by 119

Forensic and Pharmaceutical Risks in the Organization of Pharmacotherapy of Covid, Post-Covid and Long-Covid Disorders. COVID-19 and Vaccination Practice Standards.

Шаповалова, В. (2022) · SSP Modern Pharmacy and Medicine · doi:10.53933/sspmpm.v2i4.69 · Cited by 112

COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study

Derwand, R., Scholz, M., & Zelenko, V. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106214 · Cited by 113

Is hydroxychloroquine beneficial for COVID-19 patients?

Li, X., Wang, Y., Agostinis, P., Rabson, A. B., Melino, G., Carafoli, E., Shi, Y., & Sun, E. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2721-8 · Cited by 111

Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

Castelnuovo, A. F. D., Costanzo, S., Antinori, A., Berselli, N., Blandi, L., Bruno, R., Cauda, R., Guaraldi, G., Menicanti, L., My, I., et al. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.08.019 · Cited by 108

Evaluating the Impact of COVID-19 on Society, Environment, Economy, and Education

Kumar, V., Alshazly, H. A., Idris, S. A., & Bourouis, S. (2021) · Sustainability · doi:10.3390/su132413642 · Cited by 109

Cuidar al que cuida: el impacto emocional de la epidemia de coronavirus en las enfermeras y otros profesionales de la salud

Bueno‐Ferrán, M., & Barrientos‐Trigo, S. (2020) · Enfermería Clínica · doi:10.1016/j.enfcli.2020.05.006 · Cited by 103

COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications

Yamamoto, V., Bolanos, J. F., Fiallos, J., Strand, S. E., Morris, K., Shahrokhinia, S., Cushing, T. R., Hopp, L., Tiwari, A., Hariri, R., et al. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200831 · Cited by 100

Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications

Allegra, A., Gioacchino, M. D., Tonacci, A., Musolino, C., & Gangemi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134782 · Cited by 98

Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing

El‐Malah, A., Gineinah, M. M., Deb, P. K., Khayyat, A. N., Bansal, M., Venugopala, K. N., & Aljahdali, A. S. (2022) · Pharmaceuticals · doi:10.3390/ph15070827 · Cited by 98

Evaluation of Data Sharing After Implementation of the International Committee of Medical Journal Editors Data Sharing Statement Requirement

Danchev, V., Min, Y., Borghi, J., Baiocchi, M., & Ioannidis, J. P. A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.33972 · Cited by 94

[Comment] The COVID‑19 pandemic as a scientific and social challenge in the 21st century

Zoumpourlis, V., Goulielmaki, M., Rizos, E. N., Baliou, S., & Spandidos, D. A. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11393 · Cited by 91

Impacts and interactions of COVID-19 response involvement, health-related behaviours, health literacy on anxiety, depression and health-related quality of life among healthcare workers: a cross-sectional study

Tran, T. V., Nguyen, H. C., Pham, L. V., Nguyen, M. H., Nguyen, H. C., Ha, T. H., Phan, D. T., Dao, H. K., Nguyen, P. B., Trinh, M. V., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-041394 · Cited by 99

COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers

Hultcrantz, M. L., Richter, J. R., Rosenbaum, C. A., Patel, D., Smith, E. L., Korde, N., Lu, S. X., Mailankody, S., Shah, U. A., Lesokhin, A. M., et al. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0102 · Cited by 91

Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians

Porta, A. D., Bornstein, K., Coye, A., Montrief, T., Long, B., & Parris, M. A. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.07.030 · Cited by 88

Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study

Zdravković, M., Berger‐Estilita, J., Zdravković, B., & Berger, D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241826 · Cited by 86

COVID-19 drug discovery and treatment options

Chan, J. F., Yuan, S., Chu, H., Sridhar, S., & Yuen, K. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01036-y · Cited by 92

The “Infodemic” of COVID‐19

Solomon, D. H., Bucala, R., Kaplan, M. J., & Nigrovic, P. A. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41468 · Cited by 87

A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)

Chen, C., Lin, Y., Chen, T., Tseng, T.-Y., Wong, H.-L., Kuo, C.-Y., Lin, W.-P., Huang, S.-R., Wang, W., Liao, J.-H., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242763 · Cited by 80

Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models

Rosenke, K., Jarvis, M. A., Feldmann, F., Schwarz, B. H., Okumura, A., Lovaglio, J., Saturday, G. A., Hanley, P. W., Meade-White, K. D., Williamson, B. N., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.143174 · Cited by 78

Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies

Luo, S., Liang, Y., Wong, T. H. T., Schooling, C. M., & Yeung, S. L. A. (2022) · International Journal of Epidemiology · doi:10.1093/ije/dyac076 · Cited by 78

Characteristics and Management of Children With COVID-19 in Turkey

Yayla, B. C. C., Özsürekçi, Y., Aykaç, K., Oygar, P. D., Gürlevik, S. L., İlbay, S., Kukul, M. G., Karahan, S., Cengiz, A. B., & Ceyhan, M. (2020) · Balkan Medical Journal · doi:10.4274/balkanmedj.galenos.2020.2020.7.52 · Cited by 73

Journal policies and editors’ opinions on peer review

Hamilton, D. G., Fraser, H. S., Hoekstra, R., & Fidler, F. M. (2020) · eLife · doi:10.7554/elife.62529 · Cited by 77

COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs

Bartoli, A., Gabrielli, F., Alicandro, T., Nascimbeni, F., & Andreoné, P. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02569-9 · Cited by 74

Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐Analysis

Putman, M., Chock, Y. P. E., Tam, H. H. Y., Kim, A. H. J., Sattui, S. E., Berenbaum, F., Danila, M. I., Korsten, P., Sánchez-Álvarez, C., Sparks, J. A., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41469 · Cited by 71

Proliferation of Papers and Preprints During the Coronavirus Disease 2019 Pandemic: Progress or Problems With Peer Review?

Vlasschaert, C., Topf, J. M., & Hiremath, S. S. (2020) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2020.08.003 · Cited by 70

Reproducible Research: A Retrospective

Peng, R. D., & Hicks, S. C. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-012420-105110 · Cited by 78

O uso político da cloroquina: COVID-19, negacionismo e neoliberalismo / The political use of chloroquine: COVID-19, denialism and neoliberalism

Caponi, S. N., Brzozowski, F. S., Hellmann, F., & Bittencourt, S. C. (2021) · Revista Brasileira de Sociologia - RBS · doi:10.20336/rbs.774 · Cited by 68

Heterocyclic compounds as antiviral drugs: Synthesis, structure–activity relationship and traditional applications

dos Santos, G. C., Martins, L. M., Bregadiolli, B. A., Moreno, V. F., da Silva‐Filho, L. C., & Silva, B. (2021) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4349 · Cited by 68

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

Prats-Uribe, A., Sena, A. G., Lai, L. Y. H., Ahmed, W.-U.-R., Alghoul, H., Alser, O., Alshammari, T. M., Areia, C., Carter, W., Casajust, P., et al. (2021) · BMJ · doi:10.1136/bmj.n1038 · Cited by 68

Pandemics and Traditional Plant-Based Remedies. A Historical-Botanical Review in the Era of COVID19

Garcia, S. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.571042 · Cited by 71

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

Sattui, S. E., Liew, J. W., Graef, E. R., Coler-Reilly, A. L. G., Berenbaum, F., Duarte‐García, A., Harrison, C., Konig, M. F., Korsten, P., Putman, M., et al. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1792778 · Cited by 68

Availability and price changes of potential medicines and equipment for the prevention and treatment of COVID-19 among pharmacy and drug stores in Bangladesh; findings and implications

Haque, M., Islam, S., Iqbal, S., Urmi, U. L., Kamal, Z. M., Rahman, A., Kamal, M., Haque, M., Jahan, I., Islam, M. Z., et al. (2020) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v19i0.48106 · Cited by 72

Publication rate and citation counts for preprints released during the COVID-19 pandemic: the good, the bad and the ugly

Añazco, D., Nicolalde, B., Espinosa, I., Camacho, J., Mushtaq, M., Gimenez, J., & Teran, E. (2021) · PeerJ · doi:10.7717/peerj.10927 · Cited by 63

Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?

Janiaud, P., Hemkens, L. G., & Ioannidis, J. P. A. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.05.009 · Cited by 64

Better engagement, better evidence: working in partnership with patients, the public, and communities in clinical trials with involvement and good participatory practice

Gobat, N., Slack, C., Hannah, S., Salzwedel, J., Bladon, G., Burgos, J. G., Purvis, B., Molony-Oates, B., Siegfried, N., Cheah, P. Y., et al. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00521-7 · Cited by 61

Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection

Palmeira, A., Sousa, E., Köseler, A., Sabırlı, R., Gören, T., Türkçüer, İ., Kurt, Ö., Pinto, M. M. M., & Vasconcelos, M. H. (2020) · Pharmaceuticals · doi:10.3390/ph13060132 · Cited by 62

The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example

Duchesneau, E. D., Jackson, B. E., Webster‐Clark, M., Lund, J. L., Reeder-Hayes, K. E., Nápoles, A. M., & Strassle, P. D. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0495 · Cited by 66

Misleading Beyond Visual Tricks: How People Actually Lie with Charts

Lisnic, M., Polychronis, C., Lex, A., & Kogan, M. (2023) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3544548.3580910 · Cited by 76

Suggestions for a Covid-19 Post-Pandemic Research Agenda in Environmental Economics

Elliott, R., Schumacher, I., & Withagen, C. A. A. M. (2020) · Environmental and Resource Economics · doi:10.1007/s10640-020-00478-1 · Cited by 59

The Application of Single‐Cell RNA Sequencing in Vaccinology

Noé, A., Cargill, T. N., Nielsen, C. M., Russell, A. J. C., & Barnes, E. J. (2020) · Journal of Immunology Research · doi:10.1155/2020/8624963 · Cited by 61

Dynamics of cross-platform attention to retracted papers

Peng, H., Romero, D. M., & Horvát, E.-Á. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119086119 · Cited by 57

Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development

Thomson, D. J., Yom, S. S., Saeed, H., Naqa, I. E., Ballas, L., Bentzen, S. M., Chao, S. T., Choudhury, A., Coles, C. E., Dover, L. L., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.06.054 · Cited by 57

Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa

Margolin, E., Burgers, W. A., Sturrock, E. D., Mendelson, M., Chapman, R. E., Douglass, N., Williamson, A., & Rybicki, E. P. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00441-3 · Cited by 58

Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications

Haque, M., Kumar, S., Charan, J., Bhatt, R., Islam, S., Dutta, S., Abhayanand, J. P., Sharma, Y., Sefah, I. A., Kurdi, A. B., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.582154 · Cited by 57

Towards a Research Agenda for Promoting Responsible Research Practices

Tijdink, J. K., Horbach, S. P. J. M., Nuijten, M. B., & O’Neill, G. (2021) · Journal of Empirical Research on Human Research Ethics · doi:10.1177/15562646211018916 · Cited by 60

Back to WHAT? The role of research ethics in pandemic times

Solbakk, J. H., Bentzen, H. B., Holm, S., Heggestad, A. K. T., Hofmann, B., Robertsen, A., Alnæs, A. H., Cox, S., Pedersen, R., & Bernabe, R. (2020) · Medicine Health Care and Philosophy · doi:10.1007/s11019-020-09984-x · Cited by 55

The National COVID Cohort Collaborative: Clinical Characterization and Early Severity PredictionPreprint

Bennett, T. D., Moffitt, R. A., Hajagos, J., Amor, B., Anand, A., Bissell, M. M., Bradwell, K. R., Bremer, C., Byrd, J. B., Denham, A., et al. (2021) · medRxiv · doi:10.1101/2021.01.12.21249511 · Cited by 55

Issues for the management of people with diabetes and COVID-19 in ICU

Ceriello, A., Standl, E., Catrinoiu, D., Itzhak, B., Lalic, N. M., Rahelić, D., Schnell, O., Škrha, J., & Valensi, P. E. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01089-2 · Cited by 54

Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist

Martínez‐López, A., Cuenca‐Barrales, C., Montero‐Vílchez, T., Molina‐Leyva, A., & Arias‐Santiago, S. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.08.006 · Cited by 52

Inconsistent and incomplete retraction of published research: A cross-sectional study on Covid-19 retractions and recommendations to mitigate risks for research, policy and practice

Frampton, G. K., Woods, L., & Scott, D. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258935 · Cited by 54

Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019

Louchet, M., Sibiude, J., Peytavin, G., Picone, O., Tréluyer, J., & Mandelbrot, L. (2020) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2020.100159 · Cited by 52

Learning from a retraction

The Editors of the Lancet Group (2020) · The Lancet · doi:10.1016/s0140-6736(20)31958-9 · Cited by 50

Potential repurposed SARS-CoV-2 (COVID-19) infection drugs

Abuo‐Rahma, G. E. A., Mohamed, M. F. A., Ibrahim, T. S., Shoman, M. E., Samir, E., & El-Baky, R. M. A. (2020) · RSC Advances · doi:10.1039/d0ra05821a · Cited by 49

Prior diagnoses and medications as risk factors for COVID-19 in a Los Angeles Health SystemPreprint

Chang, T. S., Ding, Y., Freund, M. K., Johnson, R., Schwarz, T., Yabu, J. M., Hazlett, C. J., Chiang, J. N., Wulf, A., UCLA Health Data Mart Working Group, et al. (2020) · medRxiv · doi:10.1101/2020.07.03.20145581 · Cited by 49

Hydroxychloroquine for covid-19: the end of the line?

Mahase, E. (2020) · BMJ · doi:10.1136/bmj.m2378 · Cited by 48

Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis

Alhumaid, S., Mutair, A. S. A., Alawi, Z. A., Alhmeed, N., Zaidi, A. R. Z., & Tobaiqy, M. A. (2020) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed5040180 · Cited by 48

SARS-CoV-2 (COVID-19) in patients with some degree of immunosuppression

Cajamarca-Barón, J., Guavita-Navarro, D., Buitrago-Bohórquez, J., Gallego-Cardona, L., Navas, Á., Cubides, H. H., Arredondo, A. M., Escobar, A., & Rojas‐Villarraga, A. (2020) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2020.08.001 · Cited by 47

Real-world evidence and product development: Opportunities, challenges and risk mitigation

Naidoo, P., Bouharati, C., Rambiritch, V., Jose, N. C., Karamchand, S., CHILTON, R. J., & Leisegang, R. F. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-021-01851-w · Cited by 47

Severe airport sanitarian control could slow down the spreading of COVID-19 pandemics in Brazil

Ribeiro, S. P., Dáttilo, W., Silva, A. C. E., Reis, A. B., Goés‐Neto, A., Alcântara, L. C. J., Giovanetti, M., Coura‐Vital, W., Fernandes, G. W., & Azevedo, V. (2020) · PeerJ · doi:10.7717/peerj.9446 · Cited by 47

Science at Warp Speed: Medical Research, Publication, and Translation During the COVID-19 Pandemic

Lipworth, W. L., Gentgall, M., Kerridge, I., & Stewart, C. L. (2020) · Journal of Bioethical Inquiry · doi:10.1007/s11673-020-10013-y · Cited by 46

Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19

Hernández, A. V., Roman, Y. M., Pasupuleti, V., Barboza, J. J., & White, C. M. (2020) · Annals of Internal Medicine · doi:10.7326/l20-0945 · Cited by 46

Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments

Califf, R. M., Hernandez, A. F., & Landray, M. (2020) · JAMA · doi:10.1001/jama.2020.13319 · Cited by 45

Beneficial Effect of Statins in COVID-19–Related Outcomes—Brief Report

Lee, H., Ahn, J., Park, J., Kang, C. K., Won, S., Kim, D. W., Park, J. H., Chung, K.-H., Joh, J.-S., Bang, J. H., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315551 · Cited by 45

COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?

Jirjees, F., Saad, A. K., AlHano, Z., Hatahet, T., Al-Obaidi, H. J., & Bashi, Y. H. D. (2021) · Infectious Disease Reports · doi:10.3390/idr13020029 · Cited by 46

The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males

Croci, S., Venneri, M. A., Mantovani, S., Fallerini, C., Benetti, E., Picchiotti, N., Campolo, F., Imperatore, F., Palmieri, M., Daga, S., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1995152 · Cited by 46

Nanomedicine as a promising strategy for the theranostics of infectious diseases

Liu, H., Zhong, W., Zhang, X., Lin, D., & Wu, J. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01316e · Cited by 44

Love thy neighbour? Allocating vaccines in a world of competing obligations

Ferguson, K. E., & Caplan, A. L. (2020) · Journal of Medical Ethics · doi:10.1136/medethics-2020-106887 · Cited by 44

HIPAA and the Leak of “Deidentified” EHR Data

Mandl, K. D., & Perakslis, E. D. (2021) · New England Journal of Medicine · doi:10.1056/nejmp2102616 · Cited by 44

Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis

Vagapova, E. R., Lebedev, T. D., & Prassolov, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-90701-w · Cited by 43

Nanomedicines Targeting Respiratory Injuries for Pulmonary Disease Management

Liu, D., Long, M., Gao, L., Chen, Y., Fang, L., Shi, Y., & Gu, N. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202112258 · Cited by 45

Retraction in the era of COVID-19 and its influence on evidence-based medicine: is science in jeopardy?

Boschiero, M. N., Carvalho, T. A., & Marson, F. A. L. (2020) · Pulmonology · doi:10.1016/j.pulmoe.2020.10.011 · Cited by 42

Real‐World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID‐19

Franklin, J. M., Lin, K. J., Gatto, N. M., Rassen, J. A., Glynn, R. J., & Schneeweiß, S. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2185 · Cited by 43

On the Importance of Data Transparency

Callaghan, S. (2020) · Patterns · doi:10.1016/j.patter.2020.100070 · Cited by 6

News in Brief

Passi, G. R. (2020) · Indian Pediatrics · doi:10.1007/s13312-020-1908-5

Learning from a retraction

The Editors of the Lancet Group (2020) · The Lancet · doi:10.1016/s0140-6736(20)31958-9 · Cited by 50

Data from Mehra et al. (2020-05-29), "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"

Mehra, M. R., Desai, S. S., Ruschitzka, F. T., & Patel, A. N. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3870966

Zweifelhafte COVID-Studien – die Grenzen des Peer Reviews und der Nutzen von Twitter

Nößler, D., & Scherer, M. (2020) · EvidenzUpdate · doi:10.69156/pod.001/2020.06.00035